← Open Payments lookup

JESSE HERRMAN: Open Payments

NPI 1154198562 · COLUMBUS, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,370 in 73 payments from 14 companies in 2025. Trend: 2023 $208 · 2024 $1,418 · 2025 $1,370

Food & beverage: $1,362Education: $8
CompanyPaymentsAmount
Otsuka America Pharmaceutical, Inc.20$470
Vanda Pharmaceuticals Inc.6$173
ABBVIE INC.13$148
Alkermes, Inc.12$136
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)4$76
Teva Pharmaceuticals USA, Inc.4$72
Neurocrine BioSciences, Inc.3$63
Janssen Pharmaceuticals, Inc2$46
Collegium Pharmaceutical, Inc.2$42
Luye Pharma (USA) Ltd.1$34

Products named: REXULTI, FANAPT, ABILIFY MAINTENA, VRAYLAR, ABILIFY ASIMTUFII, ARISTADA, CAPLYTA, INGREZZA.

Industry payments across IN — which companies pay providers there.